This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Researchers analyze how the proteome of specific brain cells changes as we age

The aging brain: protein mapping furnishes new insights
Stained mouse microvessels under the fluorescence microscope (green: vascular endothelium, red: cell nuclei). Credit: Dichgans Lab

For the neurons in the brain to work smoothly and be able to process information, the central nervous system needs a strictly regulated environment. This is maintained by the blood–brain barrier, whereby specialized brain endothelial cells lining the inner walls of blood vessels regulate the exchange of molecules between the circulatory and nervous systems.

Earlier studies have shown that various functions that are dependent on these cells, such as the integrity of the blood–brain barrier or the regulation of blood supply to the brain, decline over the course of a person's life. This dysregulation leads to a dysfunction of the brain vasculature and is therefore a major contributor to medical conditions such as strokes and dementia.

However, the that underlie this loss of function have remained largely obscure. To improve our mechanistic understanding, researchers carry out molecular profiling studies to investigate the different components of brain and collect their findings in large databases.

"The transcriptome—that is to say, the RNA contained in endothelial cells—has since been quite comprehensively mapped," says LMU professor Martin Dichgans, Director of the Institute for Stroke and Dementia Research at University of Munich Hospital and Principal Investigator at the SyNergy Cluster of Excellence. "What has been lacking is corresponding data on the complete set of proteins in the cells, the proteome."

A study recently published in the journal Nature Aging, which had major contributions by researchers from LMU and SyNergy, has now closed this knowledge gap.

Dysregulated metabolism

For the study, the team developed a protocol for enriching brain endothelial cells in mice, which makes it possible to resolve age-related changes in . Using an unsupervised (computer-aided) cluster analysis, the scientists then related these protein dynamics to biological functions.

"Our results show a dysregulation of key molecules involved in the uptake of substances into cells, in receptor recycling, and in the degradation of molecules within specific cellular compartments called lysosomes," says Dichgans.

One of the most striking changes concerned a decrease in proteins involved in vesicle-mediated transport. In addition, the study provides evidence that deficiency of apolipoprotein E, a protein involved in lipid metabolism results in a signature of accelerated endothelial aging.

"The results complement and expand findings from studies on the RNA sequencing of brain endothelial cells during aging," summarizes Dichgans. "Our proteomic approach captures processes that are not detected at the RNA level."

Overall, the study offers a framework for understanding important endothelial signaling pathways during aging and serves as a data basis for future analyses of brain endothelial function. The researchers are making their data on age-related protein abundance of the mouse endothelium available in a publicly accessible database for further use.

More information: Katalin Todorov-Völgyi et al, Proteomics of mouse brain endothelium uncovers dysregulation of vesicular transport pathways during aging, Nature Aging (2024). DOI: 10.1038/s43587-024-00598-z

Journal information: Nature Aging
Citation: Researchers analyze how the proteome of specific brain cells changes as we age (2024, March 22) retrieved 30 May 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Blood–brain barrier integrity depends on a protein that is altered in some neurodegenerative diseases, study reveals


Feedback to editors